Of note, a particularly high prevalence of FGF amplifications can be found in HNSCC, particularly affecting FGF3 (22.9%), FGF4 (21.2%), and FGF19 (22.6%) [24]. This evidence concerns the gene FGF19 and head and neck squamous cell carcinoma.